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Introduction
Although melanoma affects both sexes, current literature shows it is more prevalent
and more deadly in men. The androgen receptor has been proven to play a role in
melanoma growth and metastasis, and may play a part in the difference in incidence
and mortality rates between sexes. Resveratrol, a naturally occurring compound with
poor bioavailability, has been shown to decrease melanoma cell growth in both in vitro
and in vivo studies and has known effects on the androgen receptor signaling pathway.
We propose that resveratrol is a potential therapeutic that can decrease melanoma
growth and invasion by targeting the androgen receptor pathway, and we review
current and future perspectives for resveratrol application methods.
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Methods
Cell culturing: A375-MA2 metastatic melanoma cells were maintained according to
American Type Culture Collection (ATCC) protocol.
Western Blotting: 50 µg of each protein sample were run through SDS-PAGE and
transferred to nitrocellulose for blotting. Western blots were performed for Ubiquitinconjugating enzyme E2 C (UBE2C), androgen receptor (AR), E-Cadherin (CDH1), NCadherin (CHD2), and β-Tubulin. (Figure 1)
Scratch Wound Assay: Five separate 10 cm plates of melanoma cells were subcultured. After they reached total confluency they were washed with PBS two times,
scratched with a pipette tip, and immediately bathed in medium containing varying
concentrations of RSV. Pictures were taken at 0, 6, 12, 18, and 24 hours. (Figure 2)
RNA Extraction and qPCR: RNA isolation from the cultured cells was performed using
the QIAGEN RNeasy kit and quantified with a Nanodrop 2000. cDNA was synthesized
and gene expression was measured using StepOnePlus Real Time PCR System.
Taqman probes CDH1, CDH2, UBE2C, and CCAR2 were utilized as AR activity
indicators. All samples were done in quadruplicate. (Figure 3)
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Figure 3. Relative mRNA Expression. No difference in cadherin or CCAR2
expression was visualized. There was a dose-dependent decrease in UBE2C
expression with increasing RSV treatment.

Bench to Bedside
50 µM

Problem: Resveratrol is lipophilic and has poor bioavailability due to high rates of first
pass metabolism by the liver, intestines, and intestinal bacteria.
Potential Solutions: Topical application with solid lipid nanoparticles, nanostructured
lipid carriers, prodrugs.
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Western Blot Results
Figure 1. Protein
Levels. Protein
samples from MA-2
cells treated with RSV
were analyzed via
Western Blot for
UBE2C, AR, CDH1,
and CDH2. Western
blots were treated with
β-Tubulin to control for
loading.
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Conclusion
Figure 2. Migration of Melanoma Cells in Scratch Wound Assay. A dosedependent decrease in melanoma migration was visualized with increasing
concentrations of RSV. The untreated plate almost reached total confluency 24
hours after the scratch.

Resveratrol is a promising therapeutic capable of altering melanoma growth and
metastasis at least partially through its interactions with the androgen receptor signaling
pathway. Future studies should examine the effects of resveratrol on melanoma that has
not metastasized yet to further characterize its ability to prevent metastasis. Additional in
vivo studies examining its effects on melanoma through innovative methods of delivery
will be useful in bringing resveratrol from bench to bedside.

